Genocea Biosciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Genocea Biosciences's past years’ income statements indicate that its last revenue has increased compared to the previous period by 21% to $1,641,000. The net income raised on -$15,420,000 and profit margin reached -940%. Total operating expenses were $53,734,000.
Profit Margin
| 2012 | 1.97M | -13.36M | -676.13% |
|---|---|---|---|
| 2013 | 731K | -20.80M | -2846.24% |
| 2014 | 308K | -35.29M | -11459.74% |
| 2015 | 670K | -42.48M | -6340.75% |
| 2016 | 235K | -49.57M | -21094.89% |
| 2017 | 0 | -56.71M | |
| 2018 | 0 | -27.81M | |
| 2019 | 0 | -38.95M | |
| 2020 | 1.35M | -43.71M | -3216.63% |
| 2021 | 1.64M | -15.42M | -939.67% |
GNCA Income Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 1.64M | 1.35M | 0 | 0 | 0 | 235K | 670K | 308K | 731K | 1.97M |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 1.64M | 1.35M | 0 | 0 | 0 | 235K | 670K | 308K | 731K | 0 |
Operating exp. | ||||||||||
Research and development | 39.02M | 33.96M | 26.95M | 25.20M | 39.20M | 33.05M | 28.04M | 23.72M | 15.69M | 11.24M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 53.73M | 48.34M | 38.98M | 39.51M | 52.63M | 48.48M | 42.03M | 33.47M | 20.65M | 14.93M |
Operating income | -52.09M | -46.98M | -38.98M | -39.51M | -55.25M | -48.24M | -41.36M | -33.16M | -19.92M | -12.95M |
Other income (expenses), net | 18.89M | 3.27M | 39K | 11.70M | -1.45M | -1.32M | -1.11M | -2.13M | -881K | -414K |
Income before tax | -33.19M | -43.71M | -38.95M | -27.81M | -56.71M | -49.57M | -42.48M | -35.29M | -20.80M | -13.36M |
Income tax expense | -17.77M | 4.65M | 985K | 12.72M | 250K | 410K | 0 | -1.16M | -422K | 0 |
Net income | -15.42M | -43.71M | -38.95M | -27.81M | -56.71M | -49.57M | -42.48M | -35.29M | -20.80M | -13.36M |
Earnings per share | ||||||||||
Basic EPS | -0.22 | -0.94 | -1.89 | -2.69 | -15.86 | -14.01 | -13.89 | -18.08 | -9.67 | -16.24 |
Diluted EPS | -0.22 | -0.94 | -1.89 | -2.69 | -15.86 | -14.01 | -13.89 | -18.08 | -9.67 | -16.24 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |